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EDITORIAL REVIEW
Chronic regulation of the proximal tubular Na/H antiporter:
From HCO3 to SRC
The proximal tubule is responsible for the reabsorption of 70 to
90% of filtered NaHCO3 and 50% of filtered NaCl. Approxi-
mately 70% of H secretion across the apical or luminal membrane
is mediated by an amiloride-inhibitable Na/H antiporter, while the
remaining 30% is likely mediated by a vacuolar H-ATPase (Fig. 1)
[1, 2]. All of apical membrane NaC1 absorption is mediated by an
amiloride-inhibitable Na/H antiporter functioning in parallel with
Cl/base exchange [3, 4]. Thus the apical membrane Na/H anti-
porter plays pivotal roles in proximal tubular acidification
(NaHCO3 absorption) and NaCI absorption. Base generated
within the cell exits the basolateral membrane on a Na-coupled
electrogenic transporter which likely transports 1 Na, 1 HCO3,
and 1 carbonate ion (Na/HCO3/C03 cotransporter) [5—8]. Na
exits the basolateral membrane on an Na/K pump and the
Na/HCO3/C03 cotransporter; the mechanism of basolateral
membrane Cl exit is unresolved. In addition to these processes,
the proximal tubule is the major Site of ammonia synthesis, and
the major site of renal tubular citrate reabsorption. The latter is of
relevance to acid/base physiology in that the excretion of one
citrate ion in the urine is equivalent to the excretion of three
bicarbonate ions.
All of the above processes are subject to acute and chronic
regulation. While acute regulation is of significant interest, phys-
iologically relevant regulation is more chronic in nature, and
generally occurs over hours and days. In this review, we will
discuss the chronic regulation of the proximal tubular Na/H
antiporter. Chronic regulation of proximal tubular H secretion
and Na absorption in most cases involves chronic regulation of the
apical membrane Na/H antiporter.
Molecular nature of Na/H antiport
The human Na/H antiporter was first cloned by genetic comple-
mentation by Sardet, Franchi and Pouyssegur [9]. This antiporter
is composed of two domains, an aminoterminal hydrophobic
domain which includes 10 to 12 membrane-spanning segments
and is responsible for transport, and a carboxyterminal hydrophyl-
lie domain that is located within the cytoplasm and effects
regulation by protein kinases. This Na/H antiporter is distributed
almost ubiquitously, and likely mediates cellular housekeeping
functions such as cell pH regulation, cell growth, cell volume
defense, and signal transduction. The structure-function relation-
ships and mechanisms regulating this Na/H antiporter (NHE-1)
have recently been reviewed [10, 11].
The possibility that multiple Na/H antiporter isoforms exist was
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first suggested by studies demonstrating differential sensitivity of
Na/H antiporters to amiloride and amiloride analogs. In general,
all Na/H antiporters are inhibited by amiloride. Potency of
inhibition is increased by hydrophobic 5-amino group substitu-
tions. When the kinetics of inhibition by amiloride and amiloride
analogs were examined, it was noted that Na/H antiporters fell
into two groups: amiloride-sensitive Na/H antiporters that were
inhibited by nanomolar concentrations of analogs such as ethyli-
sopropylamiloride (EIPA), and amiloride-resistant Na/H anti-
porters that required micromolar concentrations of EIPA for
inhibition [12]. Qualitatively similar but less dramatic differences
in amiloride sensitivity also exist. Amiloride-sensitive Na/H anti-
porters are distributed almost ubiquitously, and when present on
epithelia, tend to be present on the basolateral membrane.
Amiloride-resistant Na/H antiporters are found on the apical
membrane of certain Na and H transporting epithelia, such as
intestine and proximal tubule.
In the renal proximal tubule, the apical membrane Na/H
antiporter that mediates transepithelial H secretion is amiloride-
resistant [13, 14]. The basolateral membrane Na/H antiporter has
been more difficult to study. Studies examining renal cortical
basolateral membrane vesicles from rat or rabbit have failed to
demonstrate Na/H antiporter activity [15, 16]. In agreement with
this, in vivo microperfusion studies in the rat have found no Na/H
antiporter activity on the basolateral membrane [5]. Studies in the
rabbit proximal tubule perfused in vitro have identified basolateral
membrane Na/H antiporter activity, but it is only present in S3
segments, and in juxtamedullary 51 and S2 segments [17]. Al-
though the amiloride sensitivity of the basolateral membrane
Na/H antiporter has not been studied, by analogy to epithelial
cells that have been studied, the basolateral membrane Na/H
antiporter is likely amiloride-sensitive and mediates housekeeping
functions. In summary, proximal tubule cells likely express two
types of Na/H antiporter. The apical membrane Na/H antiporter
is amiloride-resistant, while the basolateral membrane Na/H
antiporter is present in only some cells.
A number of Na/H antiporter isoforms have been identified by
homology cloning in rat and rabbit. All of the isoforms share the
same topology described above. The N-terminal portion includes
10 to 12 membrane spanning domains and mediates transport,
while the C-terminal portion is cytoplasmic and mediates regula-
tion. Because the cytoplasmic domains are less conserved (30 to
40%), each of the isoforms may be regulated by distinct mecha-
nisms. Structure-function relationships and regulation of the
different isoforms have recently been reviewed [11, 18]
NHE-1 refers to the isoform initially cloned by Sardet et al [9].
It encodes an amiloride-sensitive Na/H antiporter that is ubiqui-
tously distributed and likely mediates housekeeping functions.
NHE-1 has been localized by immunocytochemistry to the baso-
lateral membrane of the rabbit proximal tubule [19]. In agreement
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Interstitium
Fig. 1. Mechanisms of proximal tubular NaHCO3 and NaCI abso,ption.
with activity measurements, only some cells in the rabbit proximal
tubule were labeled, and there was no labeling of the rat proximal
tubule. NHE-2 encodes an EIPA-resistant Na/H antiporter, but
likely does not encode the proximal tubule apical membrane
Na/H antiporter in that: (1) it is only slightly resistant to EIPA and
not resistant to amiloride [20, 21]; (2) in the rabbit mRNA
expression is greater in renal medulla than cortex [21]; and (3) in
the rat renal expression is extremely low [22, 23]. NHE-4 also does
not encode the proximal tubule apical membrane Na/H antiporter
in that expression is greater in renal medulla than cortex and by
immunocytochemistry expression has been localized to the baso-
lateral membrane of the collecting duct [24—26]. In addition,
under isotonic conditions, NHE-4 exhibits no activity [26].
NHE-3 is the best candidate to encode the apical membrane
Na/H antiporter based on the following observations: (1) NHE-3
mRNA expression is high in kidney and higher in kidney cortex
than in medulla [27, 28]; (2) NHE-3 encodes an amiloride and
EIPA-resistant Na/H antiporter [29, 30]; (3) NHE-3 protein has
been localized by immunocytochemistry to the apical membrane
of the proximal tubule [31]; (4) the ontogeny of apical membrane
Na/H antiporter activity parallels that of NHE-3 protein and
mRNA [32]; and (5) glucocorticoids which increase apical mem-
brane Na/H antiporter activity, increase renal NHE-3 mRNA
abundance [33]. Thus, evidence suggests that in the proximal
tubule the apical membrane Na/H antiporter is encoded by
NHE-3, while the basolateral membrane Na/H antiporter is
encoded by NHE-1.
To study the mechanisms responsible for chronic regulation of
the Na/H antiporter, epithelial cell culture has been extremely
useful. Such systems allow one to examine chronic regulation in a
relatively "clean" system. In general, most cultured cells express
an amiloride-sensitive Na/H antiporter and NHE-1 mRNA [34,
35]. Two epithelial cell lines have been identified that express an
amiloride-resistant Na/H antiporter, OK and LLC-PK1 cells [12,
35, 36]. In both of these epithelia, the amiloride-resistant Na/H
antiporter is located exclusively on the apical membrane, and is
inhibited by cyclic AMP-activated pathways, similar to the proxi-
mal tubular apical membrane Na/H antiporter. By Northern blot,
OKP cells, a clone of OK cells, do not express NHE-1 or NHE-3
mRNA. However, by polymerase chain reaction using primers
from sequences conserved between rat, rabbit, and human
NHE-3, a PCR product was identified from reverse transcribed
OKP mRNA [37]. This PCR product was used to screen a
dexamethasone-primed OKP cell cDNA libraiy, yielding clones
that included a full-length coding sequence with a predicted
amino acid sequence 86% identical to rat NHE-3. Injection of
cRNA from this clone into Xenopus oocytes led to expression of
an amiloride-resistant Na/H antiporter with kinetics similar to
that of the native OKP Na/H antiporter [37]. It is therefore
concluded that OKP cells express an amiloride-resistant apical
membrane Na/H antiporter that is encoded by NHE-3.
Chronic regulation of the proximal tubule Na/H antiporter in
vivo
A number of conditions have been demonstrated to elicit
chronic adaptations in the proximal tubule that result in increased
apical membrane Na/H antiporter activity in association with
increased rates of transepithelial H secretion. In chronic meta-
bolic acidosis, there is an increased capacity for proximal tubule H
secretion that is associated with parallel increases in the activities
of the apical membrane Na/H antiporter and the basolateral
membrane Na/HCO3/C03 cotransporter [38—40]. Kinetically,
both of these increases represent an increase in the V,,,ax with no
change in the affinity for Na [39].
In chronic metabolic acidosis the filtered load of bicarbonate is
decreased and thus the total amount of bicarbonate absorption
and H secretion is decreased. It has been argued that since there
is decreased requirement for H secretion, there is no physiologic
need for an increase in the Vax of these H/HCO3 transporters.
However, the proximal tubule is a pump-leak system with a
significant leak. In the late proximal tubule, it has been estimated
that the leak rate is equal to approximately 70% of the rate of
active apical membrane H secretion [41]. Because of this contin-
ued large leak, changes in "pump" rate will have a significant
effect on end proximal pH and HCO3 concentration, and thus on
distal delivery of HCO3. Since the capacity of the distal nephron
to secrete H ions is limited compared to that of the proximal
tubule, significant changes in distal delivery of HC03 can have
profound effects on renal net acid excretion. Thus, changes in
Na/H antiporter activity can have significant effects on distal
delivery of HC03 and renal net acid excretion. In addition, the
apical membrane Na/H antiporter mediates transport of NH4
from cell to lumen [42—44]. Thus, increased Na/H antiporter
activity in metabolic acidosis would contribute to increased NH4
secretion in this setting.
Similar to effects described above, chronic potassium depletion
is also associated with an increased capacity for proximal tubule H
secretion, and increased activities of the apical membrane Na/H
antiporter and the basolateral membrane Na/HCO3/C03 cotrans-
porter [45, 46]. In addition, both chronic metabolic acidosis and
chronic potassium depletion cause increases in ammoniagenesis
and citrate reabsorption in the proximal tubule [47, 48]. In both
conditions, phosphate-dependent glutaminase and phosphoenol-
pyruvate carboxykinase, rate limiting enzymes in ammoniagenesis,
are increased in activity [48]. Similarly, in both conditions, the
activity of the apical membrane Na/citrate cotransporter and the
activity of ATP citrate lyase, are increased [49—51]. Given all of
these similarities, it would appear that both conditions activate a
Lumen Na Cl
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similar Set of signalling events within the proximal tubule. While
chronic metabolic acidosis causes extracellular and intracellular
acidosis, chronic potassium depletion causes extracellular alkalo-
sis with intracellular acidosis [52]. Thus, the key signal for these
adaptations is generated in response to intracellular acidosis.
Chronic hyperfiltration is also associated with chronic increases
in the capacity of the proximal tubule for H secretion, and with
parallel increases in the activities of the apical membrane Na/H
antiporter and the basolateral membrane Na/HCO3/C03 cotrans-
porter [53]. This adaptation is of significant physiologic impor-
tance for the maintenance of glomerulotubular balance. If chronic
increases in glomerular filtration rate were not associated with
parallel increases in proximal tubular H secretion and Na absorp-
tion, there would be massive bicarbonaturia, severe metabolic
acidosis and NaCl wasting. In spite of the similarities between
chronic hyperfiltration and chronic metabolic acidosis and potas-
sium deficiency, some notable differences exist. Chronic hyperfil-
tration is not associated with a decrease in proximal tubule cell pH
[53]. It is also not associated with decreases in urinary citrate
excretion or adaptations in the Na/citrate cotransporter or in ATP
citrate lyase activity (unpublished observation, Melnick J, Levi M,
Moe OW, Srere PA, Preisig PA, and Alpern RJ). Thus, while
chronic hyperfiltration elicits changes in H transport and in Na/H
antiporter activity similar to that of chronic metabolic acidosis and
chronic potassium deficiency, the signalling pathways are likely
distinct.
Poorly controlled diabetes mellitus is associated with increases
in apical membrane Na/H antiporter activity [54]. This adaptation
may be related to: (1) metabolic acidosis or an increase in
extrarenal acid generation; (2) hyperfiltration; or (3) a direct
effect of increased extracellular glucose concentration. In the
intact animal, this adaptation is prevented by insulin treatment. It
is also prevented by NaHCO1 administration, suggesting an
important role for metabolic acidosis or increased extrarenal acid
generation [541. However, it is possible that the effects of
NaHCO3 administration and diabetes mellitus are additive rather
than both being the consequence of changes in pH. As will be
discussed below, preliminary studies in cultured cells suggest a
direct effect of hyperglycemia to increase Na/H antiporter activity
[55].
Results in chronic respiratory acidosis have been conflicting.
Two groups have found that chronic respiratory acidosis causes an
increase in apical membrane Na/H antiporter activity, while two
groups have found no effect [56—59]. As all of these studies appear
to have been carefully performed, it is likely that respiratory
acidosis increases Na/H antiporter activity, but there are con-
founding in vivo effects which obscure the regulatory influence of
chronic respiratory acidosis in some settings. Chronic respiratory
alkalosis causes a decrease in apical membrane Na/H antiporter
activity [601. Table 1 summarizes the conditions that chronically
regulate proximal tubule apical membrane Na/H antiporter activ-
ity, and their effect on proximal tubule cell pH.
Chronic regulation of the Na/H antiporter by acid in vitro
In all of the above studies, chronic adaptations have been
examined in the intact animal. While the in vivo setting offers the
opportunity to demonstrate the physiologic relevance of an effect,
it imposes many limitations when examining the mechanisms of
regulation. This is especially true in the case of chronic regulation,
where perturbations such as acidosis can elicit many systemic
Table 1. Chronic regulation of the proximal tubule apical membrane
Na/H antiporter in vivo
Condition Na/H antiporter Cell pH
Metabolic acidosis ¶
K deficiency j,
Hyperfiltration ¶ —
Diabetes mellitus 1' ?
Respiratory acidosis 1' —
Respiratory alkalosis —
effects, each of which can themselves regulate the Na/H anti-
porter. Thus, it is difficult to determine from studies performed in
vivo whether acid affects the proximal tubule directly, or whether
the effect is mediated by hemodynamic effects, changes in renal
nerve activity, or changes in the activity of an endocrine or
paracrine factor. Epithelial cell culture provides an ideal approach
to examine whether decreases in extracellular fluid pH directly
affect proximal tubule cells.
When rabbit proximal tubule cells in primary culture were
incubated in acid (pH 7.0) for 48 hours, an increase in Na/H
antiporter activity was observed that persisted for one hour after
removal from the acid media [61]. This effect occurred whether
media was acidified by lowering bicarbonate concentration or by
increasing pCO2. In addition, this effect was inhibited by cyclo-
heximide, suggesting that it is dependent on protein synthesis.
However, these studies did not address whether the protein
synthesized was the Na/H antiporter per se. Subsequent studies in
our laboratory have determined that these rabbit proximal tubule
primary cultures express an amiloride-sensitive rather than an
amiloride-resistant Na/H antiporter, and express NHE-1 mRNA
rather than NHE-3 mRNA (unpublished observation). Thus,
somewhat unexpectedly rabbit proximal tubule cells cultured
under the conditions utilized express the housekeeping Na/H
antiporter rather than the apical membrane Na/H antiporter
isoform. Increases in pCO2 have also been found to increase
apical and basolateral membrane Na/H antiporter activity in a
number of renal cell lines [62].
To examine further whether chronic acidosis increases NHE-1
or NHE-3 activity, studies were performed in established cell
lines. MCT cells, an SV4O transformed mouse proximal tubule cell
line, express an amiloride-sensitive Na/H antiporter and NHE-1
mRNA [35]. Incubation of MCT cells in acid media (pH 7.0) X 24
hours increased Na/H antiporter activity (Fig. 2). This was asso-
ciated with a threefold increase in NHE-1 mRNA abundance
(Fig. 3). The increase in NHE-1 mRNA abundance was not
apparent at 4 or 12 hours. As described above OKP cells express
an amiloride-resistant Na/H antiporter encoded by NHE-3. Incu-
bation of OKP cells in acid media for 24 hours also caused an
increase in Na/H antiporter activity (Fig. 2). This was associated
with a twofold increase in NHE-3 mRNA abundance [37].
In agreement with these results, it has been demonstrated in
LLC-PK1 cells that incubation in acid media increases the activ-
ities of amiloride-sensitive and amiloride-resistant Na/H antiport-
ers [34]. In these cells, the apical membrane Na/H antiporter is
amiloride-resistant while the basolateral membrane Na/H anti-
porter is amiloride-sensitive. Incubation in acid media (pH 6.9) )<
48 hours caused a 72% increase in apical membrane Na/H
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Fig. 2. Effect of 24 hours of acid preincubation on Na/H antiporter activity
in MCT and OKP cells. Symbols are: (E) control; () acid. Results are
expressed as the rate of sodium dependent cell pH recovery from an acid
load (dpHi/dt). In both cell lines, incubation in acid media caused a
signficant increase in Na/H antiporter activity. Used with permission from
J Clin Invest 88:1703, 1991 [35].
antiporter activity, and an 84% increase in basolateral membrane
Na/H antiporter activity. Incubation in acid media also caused a
70% increase in NHE-1 mRNA abundance in these cells. In
summary, incubation of renal epithelial cells in acid media x 24 to
48 hours leads to increases in the activities and mRNA abundance
of NHE-1 and NHE-3.
NHE-1 is distributed ubiquitously, and thus could be regulated
by acidosis in all cells. Chronic incubation of primary cultures of
human foreskin fibroblasts or NIH 3T3 cells, a mouse fibroblast
cell line, in acid media (pH 7.0) caused a decrease in Na/H
antiporter activity [35, 611. In NIH 3T3 cells, decreased activity
was associated with decreases in NHE-1 mRNA abundance [351.
Thus, the increase in Na/H antiporter activity observed with
chronic acidosis in renal epithelial cells is a tissue-specific effect.
This specificity does not reside in the specific isoform regulated in
that the same isoform, NHE-1, is increased in renal epithelial cells
and decreased in fibroblasts in response to acidosis. Metabolic
acidosis also leads to increased Na/H antiporter activity and
NHE-1 mRNA abundance in human lymphocytes [63].
Chronic regulation of the Na/il antiporter by hyperosmolality
in vitro
As described above, poorly controlled diabetes mellitus is
associated with increases in renal cortical apical membrane Na/H
antiporter activity [54]. To examine whether hyperglycemia per se
could directly increase Na/H antiporter activity, the effect of
increasing media glucose concentration was examined in OKP
cells (which express NHE-3). Increases of 20 mOsm/liter, corre-
sponding to an increase in glucose concentration from 100 mg/dl
to 450 mg/dl, caused a 40 to 80% increase in Na/H antiporter
activity [55]. The adaptive increase in Na/H antiporter activity
required 48 hours of exposure. Similar increases in Na/H anti-
porter activity were seen when extracellular fluid osmolality was
increased with mannitol or raffinose, but no effect was seen with
urea. These results suggest that cell shrinkage is responsible for
triggering the chronic increase in Na/H antiporter activity. The
increase in Na/H antiporter activity was not associated with
changes in NHE-3 mRNA abundance. It, however, likely involved
NHE-3 in that the increase in activity was EIPA-resistant.
A similar effect of increased glucose concentration to chroni-
cally increase Na/H antiporter activity has been found in cultured
vascular smooth muscle cells [64]. However, a number of differ-
ences exist. First, the isoform regulated was NilE-i. Increases in
glucose concentration caused a threefold increase in NHE-1
mRNA abundance. Second, there was no effect of mannitol or
L-glucose, suggesting an effect specific to glucose. The effect in
vascular smooth muscle cells was found to be mediated by protein
kinase C activation. In cultured renal inner medullasy collecting
duct cells, which express NHE-1 and NHE-2, incubation in
hypertonic media (510 mOsm/liter) X 72 hours caused an increase
in Na/H antiporter activity with a decrease in NHE-1 and an
increase in NHE-2 mRNA abundance [65]. It is presently not
clear which signalling pathways are activated by hypertonicity in
cultured renal cells.
In contrast to the chronic effect of hypertonicity to increase
NHE-3 activity, hypertonicity acutely inhibits NHE-3 activity. This
has been found in proximal tubule cells, OK cells, and LLC-PK1
cells [66]. In addition, the thick ascending limb apical membrane
Na/H antiporter, which is likely encoded by NHE-3, is inhibited
acutely by hypertonicity [67]. In antiporter deficient fibroblasts
transfected with different NHE isoforms, NHE-1 and NHE-2
activity are increased and NHE-3 activity is decreased by acute
hypertonicity [68]. Of significant interest, NHE-4 expressed in
fibroblasts exhibits no activity under isotonic conditions, and only
functions as an Na/H antiporter under hypertonic conditions [26].
Chronic regulation by signalling pathways
Cell culture provides an ideal tool for examining the effect of
chronic signalling pathway activation on Na/H antiporter activity.
Such studies would be impossible to interpret in an intact animal
in that signalling pathways would be activated in many cells
leading to multiple systemic effects. By utilizing the cultured cells
described above, one can examine NHE-1 and NHE-3 separately.
Chronic activation of protein kinase C stimulates NilE-i and
inhibits NHE-3
The effect of protein kinase C activation on NHE-1 was
examined in primary cultures of rabbit proximal tubule cells. As
noted above, under the conditions studied these cells express an
amiloride-sensitive Na/H antiporter that is encoded by NHE-l. In
2.5
2.0 P<0.01
P<0.02
con acid
Na/H
j3-actin
Fig. 3. Chronic incubation in acid media causes a threefold increase in
NHE-1 mRNA abundance in MCT cells. Used with permission from J Clin
Invest 88:1703, 1991 [35].
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these cells, activation of protein kinase C by the application of a
phorbol ester, PMA (phorbol 12-myristate, 13-acetate), caused an
increase in Na/H antiporter activity within five minutes [69]. This
acute increase in Na/H antiporter activity was not inhibited by
actinomycin D nor by cycloheximide, demonstrating that it is not
dependent on transcription or translation. These results agree
with the demonstration in fibroblasts that activation of protein
kinase C leads to an increase in Na/H antiporter activity that is
associated with phosphorylation of NHE-1 [70].
When PMA was applied to proximal tubule cells for five
minutes and then removed, Na/H antiporter activity returned to
control levels 24 hours later. Thus, short term activation of protein
kinase C leads to a transient increase in NHE-1 activity. Appli-
cation of phorbol esters for two hours, however, led to an increase
in Na/H antiporter activity that persisted 24 hours later [69]. This
latter effect was inhibited by actinomycin D and cycloheximide,
suggesting that it is dependent on transcription and translation. In
addition, application of PMA X two hours led to a twofold
increase in NHE-1 mRNA abundance measured four hours later.
Thus, short term activation of protein kinase C leads to an acute
transient increase in NHE-1 activity [701, while long term activa-
tion leads to a chronic persistent increase in Na/H antiporter
activity. The former is independent of transcription and transla-
tion, while the latter is dependent on such processes. These results
are analogous to those of studies examining short and long term
memory in Aplysia sensory neurons. In these cells, memory is
mediated by cyclic AMP-induced inhibition of K channel activity.
Short term increases in cAMP (5 mm) lead to a transient decrease
in K channel activity that is independent of transcription and
translation; long term increases in cAMP (2 hr) lead to a chronic
persistent decrease in K channel activity that is dependent on
transcription and translation [71]. Thus, acute and chronic regu-
lation of transporter activity in the kidney is analogous both
functionally and mechanistically to short and long term memory in
the central nervous system.
The acute effect of protein kinase C on the Na/H antiporter
represents the only discrepancy between regulation of the proxi-
mal tubule apical membrane Na/H antiporter and regulation of
NHE-3. Application of phorbol esters to brush border membrane
vesicles causes an acute increase in Na/H antiporter activity [72].
Conversely, application of phorbol esters to cultured cells inhibits
amiloride-resistant Na/H antiporter activity acutely [73, 74]. Sim-
ilarly, phorbol esters inhibit NHE-3 expressed in fibroblasts [30].
A number of possible explanations exist for this apparent discrep-
ancy. First, it is possible that the renal proximal tubule provides a
unique environment leading to tissue specific regulation of
NHE-3. Second, it is possible that the increase in Na/H antiporter
activity observed in response to protein kinase C activation does
not involve NHE-3, but rather involves a different isoform. Lastly,
it is possible that the antiporter is regulated in an aberrant fashion
when agonists are applied directly to vesicles. While phorbol
esters have been shown to increase Na/H antiporter activity in
proximal tubule suspensions [75], it is not clear in these studies
whether the apical or basolateral membrane Na/H antiporter was
being studied.
In OKP cells, acute application of PMA for 10 minutes caused
an acute 16% decrease in Na/Fl antiporter activity. Application of
phorbol esters for 24 hours led to a more pronounced 52%
decrease in Na/H antiporter activity [731. Thus, these studies
suggest that activation of protein kinase C acutely and chronically
leads to increases in NHE-1 and decreases in NHE-3 activity.
Further studies are required to address the mechanisms of
regulation in the intact proximal tubule.
Increases in cyclic AMP (cAMP) acutely inhibit and chronically
stimulate NHE-3
Acute regulation of the Na/H antiporter by cAMP and cAMP-
dependent protein kinase A is believed to play a key role in the
regulation of proximal tubular Na transport by a number of
hormones. Parathyroid hormone and dopamine increase adenylyl
cyclase activity and acutely inhibit apical membrane Na/H anti-
porter activity [76—78]. Conversely, angiotensin II, endothelin,
and catecholamines interacting with alpha 2 adrenergic receptors
inhibit adenylyl cyclase activity and acutely increase Na/H anti-
porter activity [79—82]. Thus, a simple model has evolved whereby
increased cAMP levels and protein kinase A activity inhibit apical
membrane Na/H antiporter activity and rates of sodium transport.
For such a model to be important, chronic effects of cAMP should
be qualitatively similar to acute effects.
8-Bromo-cAMP acutely inhibits Na/H antiporter activity in
OKP cells, OK cells, LLC-PK1 cells, proximal tubule cells, and
brush border membranes [74, 76, 77, 83, 84]. However, application
of iO— M 8-bromo-cAMP to OKP cells for 24 hours caused an
unexpected increase in Na/H antiporter activity [83]. A similar
effect was observed if 8-bromo-cAMP was added for six hours and
then removed for 18 to 20 hours prior to measurement of Na/H
antiporter activity. Thus, long-term increases in cAMP levels lead
to a chronic persistent increase in Na/H antiporter activity.
Similarly, application of forskolin for six hours, leading to in-
creased rates of endogenous cAMP generation, caused an in-
crease in Na/H antiporter activity 18 to 20 hours later. This effect
was inhibited by cycloheximide, and is thus dependent on protein
synthesis. These studies therefore show that while short term
increases in cAMP acutely inhibit NHE-3 activity, long term
increases in cAMP lead to chronic increases in NHE-3 activity.
Such biphasic regulation of the Na/H antiporter, if relevant to the
intact proximal tubule, suggests a greater degree of complexity
than was originally thought.
There is a precedence in the literature for possible biphasic
regulation of the Na/H antiporter by cAMP. Infusion of PTH into
humans causes an acute decrease in renal acidification and
metabolic acidosis which over a few days evolves into an increased
rate of renal acidification and chronic metabolic alkalosis [85]. In
rats and dogs, chronic increases in PTH levels also lead to a
chronic metabolic alkalosis [86, 87]. This temporally biphasic
regulation of renal acidification could be attributable to tempo-
rally biphasic regulation of the Na/H antiporter as found in OKP
cells, or may be related to chronic effects on distinct acidification
processes that override persistent inhibition of the Na/H anti-
porter.
As an initial step to examine this, effects of acute and chronic
PTH application to OKP cells were examined. iO M PTH
acutely inhibited the Na/H antiporter at 45 minutes, but chroni-
cally increased Na/H antiporter activity at 24 hours in OKP cells
[73]. This temporally biphasic effect was not attributable to
receptor desensitization in that PTH induced increases in cAMP
generation were similar during the first and 24th hours of
incubation. Thus, the effects of cAMP to acutely inhibit and
chronically stimulate NHE-3 activity in OKP cells are likely
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Table 2. Chronic regulation of the Na/H antiporter in cultured
proximal tubule cells
NHE-1 NHE-3
Acidosis I I
Hyperosmolality ? 1'
Protein kinase C I
Protein kinase A ? I
Glucocorticoids — I
relevant to biphasic regulation of renal acidification by PTH. If
cAMP and protein kinase A exert temporally biphasic effects on
apical Na/H antiporter activity, it is unlikely that they would
provide the principal pathway for regulation of Na/H antiporter
activity by angiotensin II, catecholamines, and endothelin.
Glucocorticoids activate NHE-3
Application of glucocorticoids in vivo leads to an increase in
apical membrane Na/H antiporter activity [88]. While such an
effect may be attributable to altered hemodynamics and secondary
increases in GFR, glucocorticoids have been shown to increase
Na/H antiporter activity in proximal tubule suspensions [89].
Similarly, addition of dexamethasone to OKP cells caused a
dose-dependent increase in Na/H antiporter activity [90]. Aldo-
sterone had no effect. This effect was seen within four hours, and
was dependent on protein synthesis.
Application of dexamethasone in vivo caused an increase in
NHE-3 mRNA abundance with no change in the mRNAs of other
Na/H antiporter isoforms [33]. Similarly, addition of dexametha-
sone to OKP cells x 24 hours caused a threefold increase in
NHE-3 mRNA abundance [91]. It is not presently clear whether
this increase in message abundance is due to an increase in
transcription rate or a change in mRNA stability. However, based
on known effects of glucocorticoid receptors in other cells, an
effect on transcription rate seems likely. Table 2 summarizes the
chronic regulation of Na/H antiporter isoforms in cultured prox-
imal tubule cells.
Acid activated signalling pathways
Acidosis has many effects on cells. As described above, chronic
metabolic acidosis causes increases in proximal tubule H/HCO3
transporters, ammoniagenic enzymes, and citrate transporters and
metabolic pathways. In addition, chronic acidosis causes increases
in cortical collecting duct H secretion, bone alkali mobilization,
and muscle catabolism 92—95]. This multitude of effects involves
regulation of many proteins. While it is possible that each of these
proteins could be regulated by pH directly, it seems more likely
that pH would activate one or more signalling pathways that could
then result in regulation of multiple proteins.
Acid activates immediate early genes in proximal tubule cells
Because acidosis modulates mRNA abundance of a number of
genes, we reasoned that transcription factors could be regulated.
Incubation of MCT cells, an SV4O transformed mouse proximal
tubule cell line, in acid media led to acute transient increases in
the mRNA of a number of immediate early genes including c-fos,
c-fun, junB, and egr-1 (Fig. 4) [96]. These genes are activated in
many diverse conditions, and their protein products serve as
transcription factors which then regulate the activities of other
genes. Inhibition of protein synthesis can lead to increases in the
abundance of these mRNAs that are of doubtful physiologic
significance. This, however, is not responsible for the effect of
acid. First, incubation of MCT cells in acid media did not affect
the rate of leucine incorporation into protein {96]. Second, prior
inhibition of protein synthesis with cycloheximide did not prevent
the effect of acid on immediate early gene mRNA abundance [96].
Addition of sufficient cycloheximide to inhibit protein synthesis by
97% caused a significant increase in immediate early gene mRNA
abundance, as found in other cells. In this setting, any effect of
acid on protein synthesis would be minimal. However, even in this
setting incubation in acid media increased the mRNA abundances
of the immediate early genes. In fact, the increase was more
pronounced and more prolonged in the presence of cyclohexi-
mide. This effect, commonly referred to as superinduction, is
typically seen with growth factor-induced activation of immediate
early genes. Nuclear runon studies demonstrated that acid incu-
bation increased rates of transcription of c-fos, c-fun, fun B, and
egr-1 [96]. Thus, incubation of proximal tubule cells in acid media
leads to an acute increase in immediate early gene expression that
is similar in many ways to that induced by growth factors in that:
(1) increases in mRNA abundance are transient; (2) the effect is
at least partially transcriptional; and (3) inhibition of protein
synthesis causes superinduction. Metabolic acidosis in rats also
causes increases in renal cortical immediate early gene expression
[96].
As noted above, the effect of acid to increase NHE-1 activity is
tissue specific and does not occur in fibroblasts [35, 61]. To
examine whether the effect of acid on immediate early genes was
tissue specific, studies were performed in NIH 3T3 cells 96]. In
these cells, incubation in acid media also caused an increase in
c-fos, funB, and egr-1 mRNA. However, in these cells the effect
appeared to be due to inhibition of protein synthesis. In 3T3 cells,
incubation in acid media inhibited leucine incorporation by 25%.
In addition, when cells were pretreated with cycloheximide once
again there was an increase in immediate early gene mRNA
abundance secondary to inhibition of protein synthesis. In 3T3
cells, however, there was no additional effect of acid incubation.
Thus, in fibroblasts it appears that acid incubation increases
immediate early gene expression only by inhibiting protein syn-
thesis. In that such a mechanism is unlikely to lead to increases in
the relevant protein, it is unlikely to be of physiologic significance.
Thus, acid induced increases in immediate early gene expression
are tissue specific.
Members of the fos and fun family form heterodimers which
comprise a transcription factor referred to as AP-1. This tran-
scription factor binds to a consensus nucleotide sequence,
TCA(G/C)TCA, referred to as an AP-1 binding site or TRE (TPA
response element). To determine if acid incubation caused an
increase in AP-1 activity, MCT cells were stably transfected with
a reporter gene construct including six copies of a TRE upstream
of a minimal interferon promoter and the reporter gene chioram-
phenicol acetyltransferase (CAT). Incubation of these cells in acid
media caused an increase in CAT activity and CAT mRNA,
demonstrating that acidosis causes an increase in AP-1 activity
97]. These studies demonstrate that the increases in fos/fun
mRNA noted above lead to synthesis of functional proteins.
As noted above, the acid-induced increases in immediate early
gene expression are similar to those induced by growth factors.
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Fig. 4. Acid incubation increases immediate early gene mRNA abundance. MCT cells were incubated in control (c) or acid (a) media, or control media
with 100 flM PMA (PMA). Cells were harvested at the times indicated and mRNA abundance measured by Northern blot. Both PMA and acid treatment
caused increases in mRNA abundance of c-fos, c-jun,junB, and egr-1. The mRNA abundance ofjunD, which is typically a constitutively expressed gene,
was unaffected. Used with permission from J Clin Invest 94:1297, 1994 [961.
The effect of growth factors on these genes is typically mediated
by calcium/protein kinase C pathways or protein tyrosine kinase
pathways. In MCT cells, inhibition of protein kinase C by PMA
pretreatment did not prevent immediate early gene activation by
acid [96]. Acid incubation had no effect on cell calcium in MCT
cells. In addition, clamping cell calcium low with BAPTA did not
prevent immediate early gene activation by acid. By contrast,
inhibition of tyrosine kinase pathways with herbimycin A, gelda-
nomycin, or tyrphostin A47 all prevented immediate early gene
activation [96]. Thus immediate early gene activation by acid is
mediated by protein tyrosine kinase pathways.
Acid activates c-src
The effect of acid media on tyrosine kinase pathways was more
directly demonstrated by performing Western blots with antiphos-
photyrosine antibodies on cell extracts [98]. Incubation of MCT
cells in acid media caused an increase in the phosphotyrosine
content of proteins of 60 to 70 and 120 kD. Cell fractionation
studies showed that these proteins were cytosolic. There was no
evidence for tyrosine phosphorylation of membrane proteins as
would be expected with activation of receptor protein tyrosine
kinases (which typically autophosphorylate). Based on these stud-
ies, the possibility was raised that acid incubation caused activa-
tion of nonreceptor protein tyrosine kinases such as c-src.
c-src is a 60 kD nonreceptor protein tyrosine kinase [991. It is a
member of a family of at least nine nonreceptor protein tyrosine
kinases, all of which possess a similar structural arrangement
including the following domains: (1) a tyrosine kinase domain; (2)
an SH2 domain that binds phosphotyrosine; (3) an SH3 domain
that binds proline-rich proteins; (4) an N-terminal domain that is
0' 15' 30' lh 2h
c-fos
c-jun
junB
junD
egr-1
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frequently myristylated; and (5) a C-terminal regulatory domain.
In the basal repressed state, the C-terminal domain is tyrosine
phosphorylated (Tyr 527 in c-src) and the phosphotyrosine binds
to the c-src SH2 domain. c-src activation is associated with
dephosphorylation of Tyr 527. v-src is an oncogene that represents
a mutated c-src, the protooncogene [100]. Although c-src is widely
distributed it has been difficult to define its function. In platelets,
c-src represents 0.4% of platelet protein and is likely involved in
thrombosis [101]. c-src is also highly expressed in brain where it
contributes to differentiation and neurite outgrowth [102]. c-src
plays an important role in osteoclast function; disruption of the
c-src gene in mice causes osteopetrosis [103]. c-src is abundantly
expressed in the proximal tubule [104], but its function there is
unclear.
To address whether acid activates c-src, c-src was immunopre-
cipitated from MCT cell extracts, and its activity measured in vitro
as the rate of enolase phosphorylation [105]. Incubation of MCT
cells in acid media caused a twofold increase in c-src activity which
peaked at 0.5 minutes. The increase was dose dependent and
could be seen with media pH changes as small as 0.07 pH units.
Based on the discussion earlier in this review, any physiologically
relevant acid signalling pathway must be activated by intracellular
rather than extracellular pH. To test this, three maneuvers were
utilized which acidified the cell in the absence of changes in
extracellular pH. All three maneuvers, sodium propionate addi-
tion, ammonium chloride prepulse, and nigericin addition, acti-
vated c-src. Thus, decreases in intracellular pH activate c-src.
Significant increases in activity were seen with cell pH changes as
small as 0.07 pH units.
It is not presently clear how decreases in cell pH activate c-src.
Decreased pH could stimulate a protein tyrosine phosphatase
with specificity for Tyr 527 of c-src, inhibit csk (a protein tyrosine
kinase with specificity for Tyr 527), directly activate c-src, regulate
c-src binding to another protein, or regulate c-src localization
within the cell. Acid activation of c-src was inhibited by orthovana-
date, suggesting a requirement for a protein tyrosine phosphatase
[105].
Signalling pathways mediating acid activation of the Na/H
antiporter
A remaining question is what pathways mediate acid activation
of the Na/H antiporter. As discussed previously, chronic activation
of protein kinase C leads to a chronic persistent increase in
NHE-1 activity and mRNA abundance [69]. This response is
similar to the effect of acid incubation. To examine whether
protein kinase C plays a role in acid activation of NHE-1, the
effect of inhibiting protein kinase C was examined. Inhibition of
protein kinase C either with sphingosine or by PMA pretreatment,
both prevented the effect of acid on NHE-1 activity [97]. Thus,
protein kinase C likely plays a key role in NHE-1 activation by
acid.
To examine the mechanism of NHE-3 regulation by acid
incubation, studies were performed in OKP cells [105]. By con-
trast to results for NHE-1, acid activation of NHE-3 was not
blocked by H7, an inhibitor of protein kinase C and protein kinase
A. Rather, acid activation of NHE-3 was inhibited by herbimycin
A, an inhibitor of tyrosine kinase pathways. These results are
similar to those described above for immediate early gene activa-
tion by acid where protein kinase C inhibitors were without effect,
PHextraceiiuiar
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Fig. 5. Acid activation of NHE-3. Decreases in extracellular pH lead to
decreases in intracellular pH which then activate c-src by a mechanism
that has yet to be determined. Increases in c-src then lead to increased
immediate early gene expression and probably to activation of other
pathways. These then lead to increases in NHE-3 activity. At least a
component of NHE-3 activation is mediated by increases in mRNA
abundance.
but tyrosine kinase inhibitors blocked acid activation [96]. To
examine whether src family members play a role in NHE-3
activation, OKP cells were stably transfected with csk (carboxy-
terminal src kinase). This nonreceptor protein tyrosine kinase
phosphorylates tyrosine 527 of c-src, and secondarily inhibits src
kinase activity [106 —1 10]. It also phosphorylates a similar tyrosine
in other members of the src family, and thus would be expected to
inhibit all src family nonreceptor tyrosine kinases [106, 111, 112].
In three clones with the highest level of csk mRNA expression,
activation of c-src by acid incubation was inhibited, as was
activation of NHE-3 activity [105]. Thus, these studies suggest that
src family kinases, and likely c-src play a key role in acid activation
of NHE-3.
Figure 5 summarizes a possible mechanism by which acid
activates NHE-3. Decreases in extracellular pH cause cell acidi-
fication which then activates c-src. Given that activation of
immediate early genes by acid is also mediated by tyrosine kinase
pathways, it seems likely that c-src is also responsible for acid
activation of immediate early genes, and that immediate early
genes may then contribute to NHE-3 activation. Additional
pathways likely contribute to NHE-3 activation and provide
specificity to immediate early gene activation [113]. Tyrosine
kinase pathways, or possibly protein kinase C, may mediate other
4?
immediate
early gene
expression
?
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effects of acid in proximal tubule cells such as the increase in
ammoniagenesis and citrate absorption. In addition these path-
ways could mediate acid effects in other cell types.
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